Zobrazeno 1 - 10
of 105
pro vyhledávání: '"F Richy"'
Publikováno v:
Value in Health. 25:S400
Autor:
Ulrike Gottwald-Hostalek, Frank A. Corvino, Meritxell Sabidó-Espin, Sandra Guedes, Florent F. Richy
Publikováno v:
Diabetes Care. 37:2291-2295
OBJECTIVE To determine whether the use of metformin in type 2 diabetic patients with various kidney functions is associated with an increased risk of lactic acidosis (LA). RESEARCH DESIGN AND METHODS This study was a retrospective analysis of U.K. pa
Publikováno v:
Epilepsy & Behavior. 16:240-245
The safety profiles of once-daily adjunctive levetiracetam (LEV) extended release (XR) (1000mg/day) and adjunctive LEV immediate release (IR) (500mg twice daily) were compared using data from three randomized, placebo (PBO)-controlled phase III clini
Autor:
Frank A. Corvino, Meritxell Sabidó-Espin, Sandra Guedes, Mark Samuelson, Anton Trochanov, Meredith Y. Smith, Florent F. Richy
Publikováno v:
Journal of managed carespecialty pharmacy. 21(8)
Health insurance administrative claims databases represent a valuable source of information regarding the safety profile of marketed products as used in actual clinical practice in a broader range of patients than that assessed in clinical trials. In
Autor:
W Ben Sedrine, Shuvayu S Sen, Margaret L. Gourlay, Olivier Ethgen, L. Radican, F. Richy, F. De Ceulaer, Jean-Yves Reginster, Philip D. Ross, Olivier Bruyère
Publikováno v:
QJM: An International Journal of Medicine. 97:39-46
Background: Risk indices have been developed to identify women at risk of low bone mineral density (BMD) who should undergo BMD testing. Aim: To compare the performance of four risk indices in White ambulatory women in Belgium. Design: Epidemiologica
Publikováno v:
Applied Health Economics and Health Policy
Background Parkinson’s disease (PD) is a progressive neurological disorder for which, at present, there is no cure. Current therapy is largely based on the use of dopamine agonists and dopamine replacement therapy, designed to control the signs and
Publikováno v:
Value in Health. 13(3)
Publikováno v:
Journal of musculoskeletalneuronal interactions. 7(2)
During the last two decades, the development of new, highly effective therapeutics (e.g. bisphosphonates, SERMs, strontium ranelate and PTH) has significantly extended the spectrum of osteoporosis therapy. However, the interest of combining bone-acti
Publikováno v:
International journal of clinical practice. 61(8)
The withdrawal of certain cyclooxygenase-2 selective drugs and the availability of over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) have increased the pressure for researching and prescribing conventional NSAIDs with a favourable effic
Publikováno v:
Revue medicale de Liege. 61(5-6)
The diagnosis of osteoporosis and the monitoring of antiosteoporosis therapies imply a better and more rational use of bone densitometry. The optimal prescription modalities of this fundamental examination are favorably correlated with the efficacy o